Investigation of new drug application for white cell disorders. Dr. Zonder has special interest in multidisciplinary care of patients with Multiple Myeloma, as well as other hematologic cancers.In addition, he is focused on the investigation of therapies for Multiple Myeloma.
Get the latest thought leadership on Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.
Thanks to our HealthTree Community for Myeloma Sponsors:
Follow Us
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811
